News
thumbnail
Therapeutic ClassFirefly emerges with $94m to develop antibody conjugatesFirefly emerges with $94m to develop antibody conjugates
Firefly Bio has launched from stealth to advance oncological therapies using degrader antibody conjugates (DACs).